These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 28739749)

  • 21. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
    May M; Nitzke T; Helke C; Vogler H; Hoschke B
    Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder.
    Bollito ER; Pacchioni D; Lopez-Beltran A; Volante M; Terrone C; Casetta G; Mari M; DePompa R; Cappia S; Papotti M
    Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases.
    Yun JP; Zhang MF; Hou JH; Tian QH; Fu J; Liang XM; Wu QL; Rong TH
    BMC Cancer; 2007 Mar; 7():38. PubMed ID: 17335582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinicopathological Features of Primary Small Cell Neuroendocrine Carcinoma of the Bladder].
    Gu YM; Liang XL; Zhang YG; Zhao HY; Jin ML; Li X; Lu J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):429-435. PubMed ID: 37407530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinicopathological features of colorectal neuroendocrine neoplasms and prognostic significance of WHO staging system].
    Zhang XH; Lu XL; Wu N; Liu B; Wang FY; Zhang RS; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):191-6. PubMed ID: 23769440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
    Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
    Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary superficial small cell neuroendocrine carcinoma of esophagus: clinicopathologic and immunohistochemical analysis of 15 cases].
    Lu J; Lü N; Xue LY; Zou SM; Liu XY; Wen P
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):736-40. PubMed ID: 22336155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of primary mammary small cell carcinoma, carcinoma with endocrine features and invasive ductal carcinoma.
    Yamamoto J; Ohshima K; Nabeshima K; Ikeda S; Iwasaki H; Kikuchi M
    Oncol Rep; 2004 Apr; 11(4):825-31. PubMed ID: 15010880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroendocrine carcinomas of the uterine cervix: A clinicopathological study.
    Sitthinamsuwan P; Angkathunyakul N; Chuangsuwanich T; Inthasorn P
    J Med Assoc Thai; 2013 Jan; 96(1):83-90. PubMed ID: 23720983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuroendocrine carcinoma of breast: a study of tumor morphology and subtyping].
    Gao LX; Liu G; Li L; Lin HY; Jin H; Cheng J; Jin ML; Ding HY
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):604-9. PubMed ID: 22177244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and Clinicopathological Significance of SOX11 in Small-Cell Lung Cancer.
    Xinli W; Lixiao W; Baoqi D; Hu H; Qiang Z
    Biomed Res Int; 2022; 2022():1707914. PubMed ID: 35402616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas.
    Wu Y; Lai Y; Zhang M; Li Z
    Diagn Pathol; 2021 Aug; 16(1):78. PubMed ID: 34454530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of synaptophysin, CD56, thyroid transcription factor-1, and Ki-67 in pulmonary high-grade neuroendocrine carcinomas.
    He Y; Zhao L; Tang X; Jiang Q; Zhao X; Cao Y
    Ann Diagn Pathol; 2024 Feb; 68():152239. PubMed ID: 38006863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinicopathological classification and prognostic factors of gastrointestinal neuroendocrine neoplasms: an analysis of 119 cases].
    Ma X; Zhao W; Zhuang C; Wang X; Tu L; Wang M; Sun Y; Cao H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):997-1001. PubMed ID: 28900989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.
    Nielsen K; Binderup T; Langer SW; Kjaer A; Knigge P; Grøndahl V; Melchior L; Federspiel B; Knigge U
    BMC Cancer; 2020 Jan; 20(1):27. PubMed ID: 31924180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and prognosis.
    Ishida M; Sekine S; Fukagawa T; Ohashi M; Morita S; Taniguchi H; Katai H; Tsuda H; Kushima R
    Am J Surg Pathol; 2013 Jul; 37(7):949-59. PubMed ID: 23759931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
    Samaratunga H; Khoo K
    Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.